{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:39:51Z","timestamp":1794440391161,"version":"4.9.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Chronic rhinosinusitis with nasal polyps (CRSwNP), is a prevalent inflammatory airway disease associated with type 2 inflammation. When CRSwNP coexist with asthma, the condition is referred to as global air disease (GAD). People how lives with CRSwNP or GAD often report a high symptom burden, for example persistent nasal obstruction, impaired smell and taste, disturbed sleep, fatigue, and reduced well-being. While these burdens have been quantified through clinical outcomes and patient-reported outcome measures (PROMs), there is limited qualitative research exploring how these peoples experience living with CRSwNP or GAD in their daily lives. The aim of the study was to describe the impact of CRSwNP or GAD on patients\u2019 everyday lives before the initiation of biologic treatment.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A descriptive qualitative interview study was conducted with 13 patients diagnosed with CRSwNP or GAD. Semi-structured interviews were analyzed using qualitative content analyzed as described by Graneheim and Lundman, resulting in the identification of thematic categories reflecting participants\u2019 lived experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five categories were identified: (1)\n                      <jats:italic>feeling constantly unwell, like having a chronic cold<\/jats:italic>\n                      , describing the persistent sense of ill health; (2)\n                      <jats:italic>loss of senses disrupting everyday life<\/jats:italic>\n                      , illustrating how impaired smell and taste influenced both social and practical activities; (3)\n                      <jats:italic>illness leading to social isolation and emotional distress<\/jats:italic>\n                      , highlighting psychological and relational consequences; (4)\n                      <jats:italic>dependence on prednisolone\u2014choosing between the lesser of two evils<\/jats:italic>\n                      , reflecting the balance between temporary relief and side effects; and (5)\n                      <jats:italic>Longing for a normal life<\/jats:italic>\n                      , expressing high expectations of biologic therapy as a potential turning point.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study showed that patients with CRSwNP or GAD experienced a substantial symptom burden, sensory loss, impaired work ability, and reduced social participation, all of which profoundly affected their daily lives. Many relied on prednisolone for temporary relief despite being aware of its serious side effects. The extensive impact of CRSwNP made participants hopeful that biologic therapy could provide more stable symptom control and help them regain a more \u201cnormal\u201d life. CRSwNP or GAD is a multifaceted condition that affects patients\u2019 emotional, psychological, and social well-being. These findings highlight the importance of adopting a holistic treatment approach, including consideration of psychosocial support to address the broader consequences of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/falgy.2025.1699186","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:44:09Z","timestamp":1766040249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Symptom burden in patients with chronic rhinosinusitis with nasal polyps or global airway disease prior to biologic treatment: a qualitative study of patients' experiences"],"prefix":"10.3389","volume":"6","author":[{"given":"Christiane","family":"Haase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Munch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente Appel","family":"Esbensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2500\/ajra.2013.27.3981","article-title":"Epidemiology and differential diagnosis of nasal polyps","volume":"27","author":"Chaaban","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"B2","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume-title":"Rhinology","author":"Fokkens","year":"2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","article-title":"Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"889221","DOI":"10.3389\/falgy.2022.889221","article-title":"White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA","volume":"3","author":"De Prins","year":"2022","journal-title":"Front Allergy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/alr.21528","article-title":"Depression and anxiety in chronic rhinosinusitis","volume":"5","author":"Tomoum","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"B7","article-title":"GINA severe asthma guide 2024","year":"2024"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0127228","DOI":"10.1371\/journal.pone.0127228","article-title":"Airway inflammation in chronic rhinosinusitis with nasal polyps and asthma: the united airways concept further supported","volume":"10","author":"H\u00e5kansson","year":"2015","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jaip.2022.02.034","article-title":"Comparison of different biologics for treating chronic rhinosinusitis with nasal polyps: a network analysis","volume":"10","author":"Cai","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s13555-021-00631-8","article-title":"Perception and experience of biologic therapy in atopic dermatitis: a qualitative focus group study of physicians and patients in Europe and Canada","volume":"11","author":"Ameen","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jcm12113671","article-title":"Biological treatment for uncontrolled chronic rhinosinusitis with nasal polyps: preliminary real-world results from a tertiary medical center","volume":"12","author":"Book","year":"2023","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/falgy.2021.761388","article-title":"Patients unmet needs in chronic rhinosinusitis with nasal polyps care: a patient advisory board statement of EUFOREA","volume":"2","author":"Claeys","year":"2021","journal-title":"Frontiers in Allergy"},{"key":"B17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1288\/00005537-199504000-00010","article-title":"Techniques for outcomes research in chronic sinusitis","volume":"105","author":"Gliklich","year":"1995","journal-title":"Laryngoscope"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOO.0000000000000595","article-title":"The relationship of chronic rhinosinusitis and depression","volume":"28","author":"Smith","year":"2020","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"B21","first-page":"95","article-title":"The qualitative research interview","volume-title":"Doing Qualitative Research","author":"Crabtree","year":"2023"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2500\/105065801781329428","article-title":"Use of the rhinosinusitis disability Index (RSDI) in rhinologic disease","volume":"15","author":"Senior","year":"2001","journal-title":"Am J Rhinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-14-89","article-title":"Patient engagement in research: a systematic review","volume":"14","author":"Domecq","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item sinonasal outcome test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jaci.2015.10.012","article-title":"Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment","volume":"136","author":"Rudmik","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B27","year":"2023"},{"key":"B28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/nur.4770130405","article-title":"A critical review of visual analogue scales in the measurement of clinical phenomena","volume":"13","author":"Wewers","year":"1990","journal-title":"Res Nurs Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nedt.2003.10.001","article-title":"Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness","volume":"24","author":"Graneheim","year":"2004","journal-title":"Nurse Educ Today"},{"key":"B30","article-title":"Declaration of Helsinki: ethical principles for medical research involving human subjects","year":""},{"key":"B31","doi-asserted-by":"publisher","first-page":"e022644","DOI":"10.1136\/bmjopen-2018-022644","article-title":"Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care","volume":"9","author":"Vennik","year":"2019","journal-title":"BMJ Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jval.2019.11.005","article-title":"Understanding the patient experience of severe, recurrent, bilateral nasal polyps: a qualitative interview study in the United States and Germany","volume":"23","author":"Hall","year":"2020","journal-title":"Value Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/falgy.2021.735030","article-title":"The management of extrapulmonary comorbidities and treatable traits; obesity, physical inactivity, anxiety, and depression, in adults with asthma","volume":"2","author":"McLoughlin","year":"2021","journal-title":"Front Allergy"},{"key":"B34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/01945998221082538","article-title":"Prevalence of depression and anxiety in patients with chronic rhinosinusitis: a systematic review and meta-analysis","volume":"168","author":"Chen","year":"2023","journal-title":"Otolaryngol Head Neck Surg (United States)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD011995","DOI":"10.1002\/14651858.CD011995.pub2","article-title":"Saline irrigation for chronic rhinosinusitis","volume":"4","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000541389","article-title":"Effectiveness of intranasal corticosteroids for sleep disturbances in patients with allergic rhinitis: a systematic review and meta-analysis","volume":"186","author":"Tabata","year":"2025","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/0003489415576181","article-title":"Altered quality of life and psychological health (SCL-90-R) in patients with chronic rhinosinusitis with nasal polyps","volume":"124","author":"Chung","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/alr.21669","article-title":"Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis","volume":"6","author":"Pekala","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-022-02241-2","article-title":"\u2018Life-changing\u2019: the experience of super-responders to biologics in severe asthma","volume":"22","author":"Lanario","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/hex.12888","article-title":"Frameworks for supporting patient and public involvement in research: systematic review and co-design pilot","volume":"22","author":"Greenhalgh","year":"2019","journal-title":"Health Expect"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40900-021-00268-z","article-title":"How to engage patient partners in health service research: a scoping review protocol","volume":"7","author":"Tscherning","year":"2021","journal-title":"Res Involv Engagem"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1699186\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:44:11Z","timestamp":1766040251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1699186\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":41,"alternative-id":["10.3389\/falgy.2025.1699186"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1699186","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1699186"}}